speb/financial-data huggingface dataset:
DuPont ROE decomposition for MAMATA.NS (annual period ending 2023-03-31)
ROE: 18.712541748984847%
Net margin: 11.351141418930505%
Asset turnover: 0.8570079550497517
Equity multiplier (leverage): 1.9235717693958039
EBIT margin: 14.182748080822346%
Interest burden factor: 1.0142608200860628
Tax burden factor: 0.7890953716690042
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MAMATA.NS (annual period ending 2024-03-31)
ROE: 27.218282990001736%
Net margin: 15.214308898645301%
Asset turnover: 0.9965890233425956
Equity multiplier (leverage): 1.7951154969966658
EBIT margin: 18.57756632557186%
Interest burden factor: 1.067426837398561
Tax burden factor: 0.7672294968986905
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAMATA.NS (annual period ending 2025-03-31)
ROE: 26.59822968458133%
Net margin: 16.24898378562432%
Asset turnover: 0.9970181320328801
Equity multiplier (leverage): 1.641812168199244
EBIT margin: 20.86143082186674%
Interest burden factor: 1.0573886419149043
Tax burden factor: 0.736626726844513
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MAMATA.NS (annual period ending 2026-03-31)
ROE: 8.051606206121349%
Net margin: 6.520735171029853%
Asset turnover: 0.8340946780595586
Equity multiplier (leverage): 1.4803711517952578
EBIT margin: 7.7717250976063275%
Interest burden factor: 1.0924182372582794
Tax burden factor: 0.7680512323314793
ROE archetype: Standard Business
DuPont ROE decomposition for MAMK (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 2.138340566025181
ROE archetype: Standard Business
DuPont ROE decomposition for MAMK (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.8927577426195783
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 4.173001198970128
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2024-12-31)
Net margin: 17.468368541329916%
Tax burden factor: 0.7500398872520342
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2025-03-31)
ROE: -1.5356421276672316%
Net margin: -13.244881698825647%
Asset turnover: 0.029333584095321965
Equity multiplier (leverage): 3.952544826580161
ROE archetype: Low Return
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2025-06-30)
Net margin: 9.969094222997068%
Tax burden factor: 1.3630811662726556
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2025-12-31)
Net margin: 17.272486260685138%
Tax burden factor: 0.7959716031038467
ROE archetype: Standard Business
DuPont ROE decomposition for MANAPPURAM.NS (quarterly period ending 2026-03-31)
ROE: 2.520922052509713%
Net margin: 27.046222923041974%
Asset turnover: 0.020073409994429938
Equity multiplier (leverage): 4.643352336207639
Tax burden factor: 0.7179546301058868
ROE archetype: Low Return
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.497038018437354
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2025-03-31)
ROE: 1.9848610719332094%
Net margin: 3.3622630824161797%
Asset turnover: 0.23215310784791604
Equity multiplier (leverage): 2.5428686065333124
EBIT margin: 6.5280642295311715%
Interest burden factor: 0.8213674328498236
Tax burden factor: 0.6270610050064899
ROE archetype: Low Return
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2025-06-30)
Net margin: 7.141079898154391%
EBIT margin: 12.181405959942676%
Interest burden factor: 0.8930465248979622
Tax burden factor: 0.6564360001709293
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2025-09-30)
ROE: 2.23325175041893%
Net margin: 5.0915515945904%
Asset turnover: 0.16801354538863789
Equity multiplier (leverage): 2.6106174568479554
EBIT margin: 5.689841132285426%
Interest burden factor: 0.7316426174347288
Tax burden factor: 1.2230691551489197
ROE archetype: Low Return
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2025-12-31)
Net margin: 2.693748356616771%
EBIT margin: 5.839456765138348%
Interest burden factor: 0.6325187855340212
Tax burden factor: 0.7293082843962426
ROE archetype: Standard Business
DuPont ROE decomposition for MANGLMCEM.NS (quarterly period ending 2026-03-31)
ROE: 6.675034685119282%
Net margin: 13.302297507549943%
Asset turnover: 0.20221517531079797
Equity multiplier (leverage): 2.481493407857608
EBIT margin: 6.915340710969186%
Interest burden factor: 0.3846264990608294
Tax burden factor: 5.001195970499394
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (annual period ending 2022-12-31)
ROE: 415.14084507042253%
Net margin: 11.351273287440428%
Asset turnover: 0.8371146483981463
Equity multiplier (leverage): 43.688380281690144
EBIT margin: 16.72363163722139%
Interest burden factor: 0.8963730569948186
Tax burden factor: 0.7572254335260116
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MAQ.DE (annual period ending 2023-12-31)
Net margin: 13.001307299793364%
Asset turnover: 0.9393333201291371
EBIT margin: 16.547885126302027%
Interest burden factor: 0.8608562691131498
Tax burden factor: 0.9126702190645353
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (annual period ending 2024-12-31)
Net margin: 9.46215139442231%
Asset turnover: 0.9680654119099044
EBIT margin: 15.314741035856574%
Interest burden factor: 0.8197190426638917
Tax burden factor: 0.7537289749285941
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.DE (annual period ending 2025-12-31)
Net margin: 9.93278851294585%
Asset turnover: 0.9748706302818212
EBIT margin: 15.806155961200641%
Interest burden factor: 0.8200048320850447
Tax burden factor: 0.7663523865645256
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (quarterly period ending 2025-03-31)
Net margin: 10.61791473734632%
Asset turnover: 0.235000562830663
EBIT margin: 15.152482835701742%
Interest burden factor: 0.8050579557428873
Tax burden factor: 0.8704188481675392
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (quarterly period ending 2025-06-30)
Net margin: 11.313760379596678%
Asset turnover: 0.249810160576371
EBIT margin: 18.44602609727165%
Interest burden factor: 0.8472668810289389
Tax burden factor: 0.7239089184060721
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (quarterly period ending 2025-09-30)
Net margin: 11.21898597626753%
Asset turnover: 0.23521522428636157
EBIT margin: 17.568192325473877%
Interest burden factor: 0.8719298245614036
Tax burden factor: 0.7323943661971831
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (quarterly period ending 2025-12-31)
Net margin: 6.651718983557549%
Asset turnover: 0.24163400935473967
EBIT margin: 12.047832585949179%
Interest burden factor: 0.7220843672456576
Tax burden factor: 0.7646048109965635
ROE archetype: Standard Business
DuPont ROE decomposition for MAR (quarterly period ending 2026-03-31)
Net margin: 9.738503155996394%
Asset turnover: 0.24022961532212936
EBIT margin: 16.05049594229035%
Interest burden factor: 0.8033707865168539
Tax burden factor: 0.7552447552447552
ROE archetype: Standard Business
DuPont ROE decomposition for MARA (quarterly period ending 2025-03-31)
ROE: -14.299939925120956%
Net margin: -249.29354229395372%
Asset turnover: 0.03318888854061311
Equity multiplier (leverage): 1.7283451516354313
EBIT margin: -81.22580464176843%
ROE archetype: Low Return
DuPont ROE decomposition for MARA (quarterly period ending 2025-06-30)
ROE: 18.961765146115635%
Net margin: 338.9039142923035%
Asset turnover: 0.03367031889068169
Equity multiplier (leverage): 1.6617089107991045
EBIT margin: -67.21932196993522%
Tax burden factor: 0.7949521446156177
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MARA (quarterly period ending 2025-09-30)
ROE: 2.469787059241674%
Net margin: 48.7833287112238%
Asset turnover: 0.02991557835876175
Equity multiplier (leverage): 1.6923519118615729
EBIT margin: -61.93177766332554%
Tax burden factor: 0.7657015645598587
ROE archetype: Low Return
DuPont ROE decomposition for MARA (quarterly period ending 2025-12-31)
ROE: -39.5135424894436%
Net margin: -844.9123639491088%
Asset turnover: 0.02461199556503796
Equity multiplier (leverage): 1.9001481952015822
EBIT margin: -164.00743398875017%
ROE archetype: Low Return
DuPont ROE decomposition for MARA (quarterly period ending 2026-03-31)
ROE: -43.35790852534907%
Net margin: -721.3734293928322%
Asset turnover: 0.028540634616981395
Equity multiplier (leverage): 2.1059330354845534
EBIT margin: -147.8054451533096%
ROE archetype: Low Return
DuPont ROE decomposition for MARINE.NS (annual period ending 2022-03-31)
ROE: 7.3122069282640245%
Net margin: 3.532606815982105%
Asset turnover: 1.0065743596225596
Equity multiplier (leverage): 2.056398635383654
EBIT margin: 6.415290811795611%
Interest burden factor: 0.8062081406680904
Tax burden factor: 0.6830174121035981
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (annual period ending 2023-03-31)
ROE: 8.262192014489212%
Net margin: 3.8453776006313554%
Asset turnover: 1.0159775197616947
Equity multiplier (leverage): 2.1148140794335717
EBIT margin: 7.412659151217641%
Interest burden factor: 0.7653113238934487
Tax burden factor: 0.6778394202505494
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (annual period ending 2024-03-31)
ROE: 10.93552142466778%
Net margin: 4.165749858779417%
Asset turnover: 1.1420596171445119
Equity multiplier (leverage): 2.2985689311579223
EBIT margin: 7.776911367517078%
Interest burden factor: 0.751178884320425
Tax burden factor: 0.7130872437025229
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (annual period ending 2025-03-31)
ROE: 11.469558185634325%
Net margin: 5.010094573646846%
Asset turnover: 1.1311978239848772
Equity multiplier (leverage): 2.023774893991173
EBIT margin: 6.927444347527614%
Interest burden factor: 0.9863060099623449
Tax burden factor: 0.7332654104753836
ROE archetype: Standard Business
DuPont ROE decomposition for MARINE.NS (annual period ending 2026-03-31)
ROE: 12.317322826109836%
Net margin: 6.684542561929612%
Asset turnover: 1.0378979400371875
Equity multiplier (leverage): 1.7753745140323007
EBIT margin: 9.087810489054435%
Interest burden factor: 0.9505133372315677
Tax burden factor: 0.7738454186380533
ROE archetype: Standard Business
DuPont ROE decomposition for MATD.L (annual period ending 2021-12-31)
ROE: -8.922622812565887%
Net margin: -4600%
Asset turnover: 0.0019093475012452266
Equity multiplier (leverage): 1.0158971115327853
EBIT margin: -4600%
ROE archetype: Low Return
DuPont ROE decomposition for MATD.L (annual period ending 2022-12-31)
ROE: -12.489344258776768%
Net margin: -1467.1641791044776%
Asset turnover: 0.008357048344912252
Equity multiplier (leverage): 1.0186101679879929
EBIT margin: -1467.1641791044776%
ROE archetype: Low Return
DuPont ROE decomposition for MATD.L (annual period ending 2023-12-31)
ROE: -29.130396157468%
Net margin: -1688.3190883190882%
Asset turnover: 0.016928696444468205
Equity multiplier (leverage): 1.0192209515123156
EBIT margin: -1688.3190883190882%
ROE archetype: Low Return
DuPont ROE decomposition for MATD.L (annual period ending 2024-12-31)
ROE: -53.837687330072384%
Net margin: -1331.219512195122%
Asset turnover: 0.03855564529520543
Equity multiplier (leverage): 1.0489354064371934
EBIT margin: -1119.2682926829268%
ROE archetype: Low Return
DuPont ROE decomposition for MATD.L (annual period ending 2025-12-31)
ROE: -23.099349323719988%
Net margin: -141.29635816906116%
Asset turnover: 0.14621629312629536
Equity multiplier (leverage): 1.1180803342823786
EBIT margin: -109.55562980287337%
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (annual period ending 2022-12-31)
ROE: -23.900979954580713%
Asset turnover: 0
Equity multiplier (leverage): 1.0812260542879066
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (annual period ending 2023-12-31)
ROE: -37.48515789559062%
Asset turnover: 0
Equity multiplier (leverage): 1.0776558974380124
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (annual period ending 2024-12-31)
ROE: -32.63600588863847%
Asset turnover: 0
Equity multiplier (leverage): 1.1551922445634826
ROE archetype: Low Return
DuPont ROE decomposition for MAX.V (annual period ending 2025-12-31)
ROE: -19.567192257886486%
Asset turnover: 0
Equity multiplier (leverage): 1.182232574025915
ROE archetype: Low Return
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4918491293388159
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2025-03-31)
ROE: 3.400537476801192%
Net margin: 16.703844502392997%
Asset turnover: 0.12552121400139865
Equity multiplier (leverage): 1.6218623645781254
EBIT margin: 21.510257940871533%
Interest burden factor: 0.9798193724287348
Tax burden factor: 0.7925465838509317
ROE archetype: Low Return
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2025-06-30)
Net margin: 15.18911800825619%
EBIT margin: 20.653787538777948%
Interest burden factor: 0.9562050767724527
Tax burden factor: 0.7690982194141297
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2025-09-30)
ROE: 4.887385214092939%
Net margin: 23.006644907210124%
Asset turnover: 0.13116348033103659
Equity multiplier (leverage): 1.6196096259503938
EBIT margin: 21.87106351295031%
Interest burden factor: 0.9549941119794454
Tax burden factor: 1.1014954151066072
ROE archetype: Low Return
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2025-12-31)
Net margin: 14.55463550533973%
EBIT margin: 20.656148429035753%
Interest burden factor: 0.8535837216381389
Tax burden factor: 0.8254786854666155
ROE archetype: Standard Business
DuPont ROE decomposition for MAXHEALTH.NS (quarterly period ending 2026-03-31)
ROE: 3.184440145422333%
Net margin: 15.970021792999173%
Asset turnover: 0.12436291926035377
Equity multiplier (leverage): 1.6033807807656915
EBIT margin: 22.558787431926042%
Interest burden factor: 0.9610475579735629
Tax burden factor: 0.7366223255413491
ROE archetype: Low Return
DuPont ROE decomposition for MBC (quarterly period ending 2025-03-31)
ROE: 1.0178311777760771%
Net margin: 2.014235953354536%
Asset turnover: 0.2233912984640368
Equity multiplier (leverage): 2.2620341317823525
EBIT margin: 6.33045585339997%
Interest burden factor: 0.4138755980861244
Tax burden factor: 0.7687861271676301
ROE archetype: Low Return
DuPont ROE decomposition for MBC (quarterly period ending 2025-06-30)
ROE: 2.7964163886493982%
Net margin: 5.103297304692845%
Asset turnover: 0.24720963268619361
Equity multiplier (leverage): 2.216591070960003
EBIT margin: 10.110822273908878%
Interest burden factor: 0.6630581867388363
Tax burden factor: 0.7612244897959184
ROE archetype: Low Return
DuPont ROE decomposition for MBC (quarterly period ending 2025-09-30)
ROE: 1.3190016396429223%
Net margin: 2.589783946201173%
Asset turnover: 0.2345577500713171
Equity multiplier (leverage): 2.1713609036254327
EBIT margin: 6.338531978823866%
Interest burden factor: 0.5282167042889391
Tax burden factor: 0.7735042735042735
ROE archetype: Low Return
DuPont ROE decomposition for MBC (quarterly period ending 2025-12-31)
ROE: -3.079066016641619%
Net margin: -6.515668631709587%
Asset turnover: 0.2112646051488783
Equity multiplier (leverage): 2.2368314944466845
EBIT margin: -4.002482159478746%
ROE archetype: Low Return
DuPont ROE decomposition for MBC (quarterly period ending 2026-03-31)
ROE: -1.1556789613898164%
Net margin: -2.4919093851132685%
Asset turnover: 0.19880651750816297
Equity multiplier (leverage): 2.3327830100183857
EBIT margin: -0.9223300970873786%
ROE archetype: Low Return
DuPont ROE decomposition for MBINN (annual period ending 2022-12-31)
ROE: 15.052074377679844%
Net margin: 49.96111727575355%
Asset turnover: 0.034861362383728806
Equity multiplier (leverage): 8.642111363743792
Tax burden factor: 0.7546867164476441
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBINN (annual period ending 2023-12-31)
ROE: 17.668436353443393%
Net margin: 49.92294352171348%
Asset turnover: 0.037833797459616715
Equity multiplier (leverage): 9.354444396285398
Tax burden factor: 0.8026110426062137
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBINN (annual period ending 2024-12-31)
ROE: 16.24513169830397%
Net margin: 48.03640370934007%
Asset turnover: 0.037304120716428836
Equity multiplier (leverage): 9.065587261313144
Tax burden factor: 0.7580552808286919
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBINN (annual period ending 2025-12-31)
ROE: 9.671382111988123%
Net margin: 32.30317169688737%
Asset turnover: 0.035406914318315344
Equity multiplier (leverage): 8.455811571397343
Tax burden factor: 0.8293025018953752
ROE archetype: Standard Business
DuPont ROE decomposition for MBUU (annual period ending 2022-06-30)
ROE: 31.822465574179077%
Net margin: 13.452390653539412%
Asset turnover: 1.4270408750584382
Equity multiplier (leverage): 1.657669480964546
EBIT margin: 17.60038259017168%
Interest burden factor: 0.9819570392333846
Tax burden factor: 0.77836782320863
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MBUU (annual period ending 2023-06-30)
ROE: 19.110598315270856%
Net margin: 7.772451768807194%
Asset turnover: 1.5623744549163032
Equity multiplier (leverage): 1.5737332432497049
EBIT margin: 10.428381585534064%
Interest burden factor: 0.9772557741186871
Tax burden factor: 0.7626633496123428
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for MBUU (annual period ending 2024-06-30)
ROE: -9.719836727882122%
Net margin: -6.744226721429132%
Asset turnover: 0.9955101864371366
Equity multiplier (leverage): 1.447708418805499
EBIT margin: 4.966859059026459%
Interest burden factor: -1.4033319571605507
ROE archetype: Low Return
DuPont ROE decomposition for MBUU (annual period ending 2025-06-30)
ROE: 2.8903268876262147%
Net margin: 1.887163941795109%
Asset turnover: 1.0955906992393172
Equity multiplier (leverage): 1.397941495535545
EBIT margin: 2.6946571218768613%
Interest burden factor: 0.9311612517807086
Tax burden factor: 0.7521097566994028
ROE archetype: Low Return
DuPont ROE decomposition for MBVI (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.050014466128435
ROE archetype: Standard Business
DuPont ROE decomposition for MBX (quarterly period ending 2025-03-31)
ROE: -10.143487014807452%
Asset turnover: 0
Equity multiplier (leverage): 1.0446177502527376
ROE archetype: Low Return
DuPont ROE decomposition for MBX (quarterly period ending 2025-06-30)
ROE: -8.53866947022067%
Asset turnover: 0
Equity multiplier (leverage): 1.0501186598366694
ROE archetype: Low Return
DuPont ROE decomposition for MBX (quarterly period ending 2025-09-30)
ROE: -7.125517282296462%
Asset turnover: 0
Equity multiplier (leverage): 1.0409062967119715
ROE archetype: Low Return
DuPont ROE decomposition for MBX (quarterly period ending 2025-12-31)
ROE: -5.830638735347091%
Asset turnover: 0
Equity multiplier (leverage): 1.0376063248502498
ROE archetype: Low Return
DuPont ROE decomposition for MBX (quarterly period ending 2026-03-31)
ROE: -5.828404456621548%
Asset turnover: 0
Equity multiplier (leverage): 1.0382488267972276
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (quarterly period ending 2025-03-31)
ROE: 0.0665187121057972%
Net margin: 0.38806624920373556%
Asset turnover: 0.1352350465456633
Equity multiplier (leverage): 1.2675021486438909
EBIT margin: 5.5822082967752795%
Interest burden factor: 0.0695184107386163
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (quarterly period ending 2025-06-30)
ROE: -5.561423190795822%
Net margin: -47.312496867963716%
Asset turnover: 0.09139892964520156
Equity multiplier (leverage): 1.2860829053272071
EBIT margin: -38.29335559023115%
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (quarterly period ending 2025-09-30)
ROE: -5.1473058138242305%
Net margin: -39.54423742855174%
Asset turnover: 0.09824481392497093
Equity multiplier (leverage): 1.3249123003050276
EBIT margin: -37.577043402830625%
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (quarterly period ending 2025-12-31)
ROE: -4.3232863081746915%
Net margin: -27.665375100529545%
Asset turnover: 0.11485925976888159
Equity multiplier (leverage): 1.3605403347681488
EBIT margin: -22.498565387402287%
ROE archetype: Low Return
DuPont ROE decomposition for MBX.TO (quarterly period ending 2026-03-31)
ROE: -5.48696215352092%
Net margin: -42.34640768236923%
Asset turnover: 0.09319104682237797
Equity multiplier (leverage): 1.3904046134752417
EBIT margin: -37.37241348275221%
ROE archetype: Low Return
DuPont ROE decomposition for MCA.AX (annual period ending 2021-06-30)
Asset turnover: 0.2240918787502836
Equity multiplier (leverage): 1.2732620027785782
ROE archetype: Standard Business
DuPont ROE decomposition for MCA.AX (annual period ending 2022-06-30)
ROE: -15.741550928942985%
Net margin: -69.71322169467194%
Asset turnover: 0.18414701924476629
Equity multiplier (leverage): 1.226217957471511
EBIT margin: -67.38526843923133%
ROE archetype: Low Return
DuPont ROE decomposition for MCA.AX (annual period ending 2023-06-30)
ROE: -9.697023425656493%
Net margin: -67.20786677741363%
Asset turnover: 0.11456155670863474
Equity multiplier (leverage): 1.2594456408115406
EBIT margin: -86.53907139542545%
ROE archetype: Low Return
DuPont ROE decomposition for MCA.AX (annual period ending 2024-06-30)
ROE: -7.694728146125751%
Net margin: -60.89656028687548%
Asset turnover: 0.0888623686076857
Equity multiplier (leverage): 1.4219444594548576
EBIT margin: -72.89885665371607%
ROE archetype: Low Return
DuPont ROE decomposition for MCA.AX (annual period ending 2025-06-30)
ROE: 8.830593800369048%
Net margin: 80.30783093528791%
Asset turnover: 0.07046892158416469
Equity multiplier (leverage): 1.5603944130445075
EBIT margin: 121.38291753584727%
Interest burden factor: 1.053576133524901
Tax burden factor: 0.6279634981343496
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (quarterly period ending 2025-03-31)
Net margin: 1.4379617497770387%
Asset turnover: 1.2087170614852276
EBIT margin: 1.832135031875186%
Interest burden factor: 0.9104567307692307
Tax burden factor: 0.862046204620462
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (quarterly period ending 2025-06-30)
Net margin: 0.8494587383851084%
Asset turnover: 1.250576857929959
EBIT margin: 1.1070563341408812%
Interest burden factor: 0.9704524469067405
Tax burden factor: 0.7906755470980019
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (quarterly period ending 2025-09-30)
Net margin: 1.127484246243335%
Asset turnover: 1.2467441424781383
EBIT margin: 1.4231701405719825%
Interest burden factor: 0.9502724795640327
Tax burden factor: 0.8336917562724014
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (quarterly period ending 2025-12-31)
Net margin: 1.1774901561822944%
Asset turnover: 1.2611583011583012
EBIT margin: 1.5589969667853576%
Interest burden factor: 0.9848942598187311
Tax burden factor: 0.7668711656441718
ROE archetype: Standard Business
DuPont ROE decomposition for MCK (quarterly period ending 2026-03-31)
Net margin: 1.926372085778078%
Asset turnover: 1.1566063910925874
EBIT margin: 2.334492964328366%
Interest burden factor: 0.9452846975088968
Tax burden factor: 0.8729411764705882
ROE archetype: Standard Business
DuPont ROE decomposition for MDXH (quarterly period ending 2025-03-31)
ROE: -154.30630026809663%
Net margin: -37.90959986826939%
Asset turnover: 0.13894402086562607
Equity multiplier (leverage): 29.295073726541577
EBIT margin: -18.886876337889014%
ROE archetype: Low Return
DuPont ROE decomposition for MDXH (quarterly period ending 2025-06-30)
ROE: -318.38213893400706%
Net margin: -27.709077241120095%
Asset turnover: 0.17609672218548836
Equity multiplier (leverage): 65.24922543211503
EBIT margin: -7.201653824469085%
ROE archetype: Low Return
DuPont ROE decomposition for MDXH (quarterly period ending 2025-09-30)
Net margin: -29.198410673276708%
Asset turnover: 0.1860419379340278
EBIT margin: -9.63073670396967%
ROE archetype: Standard Business
DuPont ROE decomposition for MDXH (quarterly period ending 2025-12-31)
Net margin: -30.218311050939246%
Asset turnover: 0.19551205696286295
EBIT margin: -21.06617024877306%
ROE archetype: Standard Business
DuPont ROE decomposition for MDXH (quarterly period ending 2026-03-31)
Net margin: -32.37785729935003%
Asset turnover: 0.1754021637562576
EBIT margin: -26.666910100051123%
ROE archetype: Standard Business
DuPont ROE decomposition for MED.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7057957470164586
ROE archetype: Standard Business
DuPont ROE decomposition for MED.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.7460053908451458
ROE archetype: Standard Business
DuPont ROE decomposition for MED.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.9104175850319944
ROE archetype: Standard Business
DuPont ROE decomposition for MEDP (annual period ending 2022-12-31)
ROE: 63.50317169055894%
Net margin: 16.8060734412971%
Asset turnover: 1.0794834731366845
Equity multiplier (leverage): 3.5003636250702015
EBIT margin: 19.08888791476141%
Interest burden factor: 1.0149373692576527
Tax burden factor: 0.8674538641023828
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (annual period ending 2023-12-31)
ROE: 59.83263111461839%
Net margin: 14.9964843290159%
Asset turnover: 1.2533330586314597
Equity multiplier (leverage): 3.183333562528495
EBIT margin: 17.86072216018097%
Interest burden factor: 0.9966065464261857
Tax burden factor: 0.8424937887643663
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (annual period ending 2024-12-31)
ROE: 58.41639009169408%
Net margin: 19.173809679600428%
Asset turnover: 1.1225256766516911
Equity multiplier (leverage): 2.714126089296097
EBIT margin: 21.188172517156982%
Interest burden factor: 1.0650121959406538
Tax burden factor: 0.8496896550275045
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDP (annual period ending 2025-12-31)
ROE: 70.2346849175162%
Net margin: 17.829299582568254%
Asset turnover: 1.2414250241270475
Equity multiplier (leverage): 3.1731957254152214
EBIT margin: 21.141720489093103%
Interest burden factor: 1.013911970613252
Tax burden factor: 0.8317517151354132
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MEDPLUS.NS (annual period ending 2023-03-31)
ROE: 3.361621360871278%
Net margin: 1.1063930328484237%
Asset turnover: 1.6192837461624663
Equity multiplier (leverage): 1.876361035651771
EBIT margin: 1.9284206435429305%
Interest burden factor: 0.540042596070169
Tax burden factor: 1.0623794075864554
ROE archetype: Low Return
DuPont ROE decomposition for MEDPLUS.NS (annual period ending 2024-03-31)
ROE: 4.2427091190049415%
Net margin: 1.1765767621379726%
Asset turnover: 1.9069635442675266
Equity multiplier (leverage): 1.8909524151165835
EBIT margin: 2.3599893927416358%
Interest burden factor: 0.5583532899988596
Tax burden factor: 0.8928965320044115
ROE archetype: Low Return
DuPont ROE decomposition for MEDPLUS.NS (annual period ending 2025-03-31)
ROE: 8.953264050293082%
Net margin: 2.469369839394533%
Asset turnover: 1.889822118118767
Equity multiplier (leverage): 1.9185553185753026
EBIT margin: 3.918166908256049%
Interest burden factor: 0.768452563129672
Tax burden factor: 0.8201365057368418
ROE archetype: Standard Business
DuPont ROE decomposition for MEDPLUS.NS (annual period ending 2026-03-31)
ROE: 11.281542336031567%
Net margin: 3.213436189117981%
Asset turnover: 1.7895693406821618
Equity multiplier (leverage): 1.9617798364892831
EBIT margin: 4.764436425975568%
Interest burden factor: 0.8454393318287197
Tax burden factor: 0.7977663167834961
ROE archetype: Standard Business
DuPont ROE decomposition for MEG.AX (annual period ending 2021-12-31)
ROE: -14.3002567960972%
Equity multiplier (leverage): 1.022968077336018
ROE archetype: Low Return
DuPont ROE decomposition for MEG.AX (annual period ending 2022-12-31)
ROE: -118.55520302448097%
Equity multiplier (leverage): 1.0340588254761343
ROE archetype: Low Return
DuPont ROE decomposition for MEG.AX (annual period ending 2023-12-31)
ROE: -20.13538776721391%
Equity multiplier (leverage): 1.0212687073183264
ROE archetype: Low Return
DuPont ROE decomposition for MEG.AX (annual period ending 2024-12-31)
ROE: -49.954351071765615%
Equity multiplier (leverage): 1.0095691504847353
ROE archetype: Low Return
DuPont ROE decomposition for MEGL (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0509902788760719
ROE archetype: Standard Business
DuPont ROE decomposition for MEGL (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0447380345946664
ROE archetype: Standard Business
DuPont ROE decomposition for MEL.MC (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 4.282536216780059
ROE archetype: Standard Business
DuPont ROE decomposition for MEL.MC (quarterly period ending 2025-03-31)
Net margin: 2.3622047244094486%
EBIT margin: 7.581552305961756%
Interest burden factor: 0.4183976261127596
Tax burden factor: 0.7446808510638298
ROE archetype: Standard Business
DuPont ROE decomposition for MEL.MC (quarterly period ending 2025-06-30)
ROE: 6.990080317544474%
Net margin: 14.278657843849304%
Asset turnover: 0.11658682173667574
Equity multiplier (leverage): 4.19899459773162
EBIT margin: 16.86147237625157%
Interest burden factor: 1.1280176201894387
Tax burden factor: 0.7507165804205221
ROE archetype: Standard Business
DuPont ROE decomposition for MEL.MC (quarterly period ending 2025-09-30)
Net margin: 14.466428803113848%
EBIT margin: 20.75900097307817%
Interest burden factor: 0.9289062499999999
Tax burden factor: 0.7502102607232969
ROE archetype: Standard Business
DuPont ROE decomposition for MEL.MC (quarterly period ending 2025-12-31)
ROE: 1.9099868098577888%
Net margin: 4.7972049993404005%
Asset turnover: 0.10096218499128899
Equity multiplier (leverage): 3.9435136607346326
EBIT margin: 13.227740636875454%
Interest burden factor: 0.46720177583322614
Tax burden factor: 0.7762437596832501
ROE archetype: Low Return
DuPont ROE decomposition for MEL.MC (quarterly period ending 2026-03-31)
Net margin: 0.7147498375568552%
EBIT margin: 5.003248862897986%
Interest burden factor: 0.19480519480519481
Tax burden factor: 0.7333333333333334
ROE archetype: Standard Business
DuPont ROE decomposition for MELI (annual period ending 2022-12-31)
ROE: 26.382047071702246%
Net margin: 4.471243042671614%
Asset turnover: 0.7847990681421084
Equity multiplier (leverage): 7.518336070060209
EBIT margin: 9.916512059369202%
Interest burden factor: 0.7296538821328344
Tax burden factor: 0.6179487179487179
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MELI (annual period ending 2023-12-31)
ROE: 40.53572519643665%
Net margin: 6.533395114847422%
Asset turnover: 0.9703935630099758
Equity multiplier (leverage): 6.3936832433256
EBIT margin: 14.609121599258623%
Interest burden factor: 0.7036701404621659
Tax burden factor: 0.6355441081777206
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MELI (annual period ending 2024-12-31)
ROE: 49.202098124239754%
Net margin: 9.197670501034798%
Asset turnover: 0.9277088990761841
Equity multiplier (leverage): 5.766257770968479
EBIT margin: 12.663040862492178%
Interest burden factor: 0.9243633599391866
Tax burden factor: 0.7857730263157895
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MELI (annual period ending 2025-12-31)
ROE: 37.55405608746374%
Net margin: 6.911708718374693%
Asset turnover: 0.8865876434904865
Equity multiplier (leverage): 6.1284373268457175
EBIT margin: 11.07880801578237%
Interest burden factor: 0.8878475476413621
Tax burden factor: 0.7026741731175229
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MESH (quarterly period ending 2025-07-31)
Equity multiplier (leverage): 4.7714381047714385
ROE archetype: Standard Business
DuPont ROE decomposition for MESH (quarterly period ending 2026-03-31)
ROE: 1.6673273368847472%
Asset turnover: 0
Equity multiplier (leverage): 1.0451748209223484
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MET (quarterly period ending 2025-03-31)
ROE: 3.4228067014952264%
Net margin: 5.194663167104112%
Asset turnover: 0.026569192057136547
Equity multiplier (leverage): 24.79971176364619
Tax burden factor: 0.7016248153618907
ROE archetype: Low Return
DuPont ROE decomposition for MET (quarterly period ending 2025-06-30)
ROE: 2.639991379619985%
Net margin: 4.279226828132278%
Asset turnover: 0.024699702182794478
Equity multiplier (leverage): 24.977299665960274
Tax burden factor: 0.75
ROE archetype: Low Return
DuPont ROE decomposition for MET (quarterly period ending 2025-09-30)
ROE: 3.1583738926433%
Net margin: 5.343285350393934%
Asset turnover: 0.02373934394415397
Equity multiplier (leverage): 24.899261178612697
Tax burden factor: 0.7454545454545455
ROE archetype: Low Return
DuPont ROE decomposition for MET (quarterly period ending 2025-12-31)
ROE: 2.8083700440528636%
Net margin: 3.503499205701773%
Asset turnover: 0.03179893125226979
Equity multiplier (leverage): 25.208080947136565
Tax burden factor: 0.7305282005371531
ROE archetype: Low Return
DuPont ROE decomposition for MET (quarterly period ending 2026-03-31)
ROE: 4.178272980501393%
Net margin: 6.365492049849592%
Asset turnover: 0.025015167528119556
Equity multiplier (leverage): 26.23985402489334
Tax burden factor: 0.7863304578633046
ROE archetype: Low Return
DuPont ROE decomposition for MEU.AX (annual period ending 2022-06-30)
ROE: -2.796195804232852%
Equity multiplier (leverage): 1.0597088412155864
ROE archetype: Low Return
DuPont ROE decomposition for MEU.AX (annual period ending 2023-06-30)
ROE: -2.059344692397514%
Equity multiplier (leverage): 1.0488856903346655
ROE archetype: Low Return
DuPont ROE decomposition for MEU.AX (annual period ending 2024-06-30)
ROE: -2.09069863459003%
Equity multiplier (leverage): 1.0408053364583791
ROE archetype: Low Return
DuPont ROE decomposition for MEU.AX (annual period ending 2025-06-30)
ROE: -8.01251560755389%
Equity multiplier (leverage): 1.0380402060605132
ROE archetype: Low Return
DuPont ROE decomposition for MFA (annual period ending 2022-12-31)
ROE: -11.643970960087971%
Asset turnover: -0.00928207207647158
Equity multiplier (leverage): 4.581748036175697
ROE archetype: Low Return
DuPont ROE decomposition for MFA (annual period ending 2023-12-31)
ROE: 4.12285240246001%
Net margin: 39.01740996899595%
Asset turnover: 0.020664422272058544
Equity multiplier (leverage): 5.113474358433682
Tax burden factor: 0.9965440938813058
ROE archetype: Low Return
DuPont ROE decomposition for MFA (annual period ending 2024-12-31)
ROE: 6.374149552597251%
Net margin: 47.16218514314641%
Asset turnover: 0.022797732281431306
Equity multiplier (leverage): 5.92838883429408
Tax burden factor: 0.9962988955169014
ROE archetype: Standard Business
DuPont ROE decomposition for MFA (annual period ending 2025-12-31)
ROE: 9.635297795032384%
Net margin: 59.20533970990613%
Asset turnover: 0.024418740014997515
Equity multiplier (leverage): 6.6647062654807065
Tax burden factor: 1.0041749977278924
ROE archetype: Standard Business
DuPont ROE decomposition for MFF.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.2094794033049416
ROE archetype: Standard Business
DuPont ROE decomposition for MGA (annual period ending 2022-12-31)
ROE: 5.6550507278341415%
Net margin: 1.6939746300211418%
Asset turnover: 1.3616898772895751
Equity multiplier (leverage): 2.4516100573445083
EBIT margin: 4.1569767441860455%
Interest burden factor: 0.5581691036236491
Tax burden factor: 0.7300683371298406
ROE archetype: Standard Business
DuPont ROE decomposition for MGA (annual period ending 2023-12-31)
ROE: 11.048766034975294%
Net margin: 3.0048835198728883%
Asset turnover: 1.4451933672575008
Equity multiplier (leverage): 2.544252299194034
EBIT margin: 4.762016029160922%
Interest burden factor: 0.788027477919529
Tax burden factor: 0.8007471980074721
ROE archetype: Standard Business
DuPont ROE decomposition for MGA (annual period ending 2024-12-31)
ROE: 8.684598901878957%
Net margin: 2.558595573816416%
Asset turnover: 1.2984163590276627
Equity multiplier (leverage): 2.61417190249636
EBIT margin: 4.939770286674759%
Interest burden factor: 0.728733459357278
Tax burden factor: 0.7107652399481192
ROE archetype: Standard Business
DuPont ROE decomposition for MGA (annual period ending 2025-12-31)
ROE: 7.274069008862083%
Net margin: 2.101880504641752%
Asset turnover: 1.3739160345130814
Equity multiplier (leverage): 2.5188900029581567
EBIT margin: 5.022613663413473%
Interest burden factor: 0.6199052132701421
Tax burden factor: 0.6750764525993883
ROE archetype: Standard Business
DuPont ROE decomposition for MGA.AX (annual period ending 2023-06-30)
ROE: -11.346903094235781%
Equity multiplier (leverage): 1.0909761897505508
ROE archetype: Low Return
DuPont ROE decomposition for MGA.AX (annual period ending 2024-06-30)
ROE: -48.176763241796465%
Equity multiplier (leverage): 1.0592081310403183
ROE archetype: Low Return
DuPont ROE decomposition for MGA.AX (annual period ending 2025-06-30)
ROE: -46.624305732180495%
Equity multiplier (leverage): 1.0246945039622046
ROE archetype: Low Return
DuPont ROE decomposition for MGAM.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.766760852812741
ROE archetype: Standard Business
DuPont ROE decomposition for MGAM.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.831709217615015
ROE archetype: Standard Business
DuPont ROE decomposition for MGAM.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.8603308591665453
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (annual period ending 2023-03-31)
ROE: 11.096612475954164%
Net margin: 0.9029837281000807%
Asset turnover: 3.2016389717227396
Equity multiplier (leverage): 3.8382931192857
EBIT margin: 1.894897456327468%
Interest burden factor: 0.6031407638722076
Tax burden factor: 0.7900881166923881
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (annual period ending 2024-03-31)
ROE: 15.849024356248641%
Net margin: 1.1115090223891921%
Asset turnover: 4.199077641849988
Equity multiplier (leverage): 3.395749423098376
EBIT margin: 1.90962028648622%
Interest burden factor: 0.6518898928249455
Tax burden factor: 0.8928771832155843
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MGEL.NS (annual period ending 2025-03-31)
ROE: 13.434482943268133%
Net margin: 1.0125593245285662%
Asset turnover: 4.6252425806228725
Equity multiplier (leverage): 2.8685733789010412
EBIT margin: 1.8422370568669528%
Interest burden factor: 0.7481215887623661
Tax burden factor: 0.7346877116878738
ROE archetype: Standard Business
DuPont ROE decomposition for MGEL.NS (annual period ending 2026-03-31)
ROE: 19.229908721996704%
Net margin: 1.3361819638584829%
Asset turnover: 4.773060714956514
Equity multiplier (leverage): 3.0151898243044086
EBIT margin: 1.7289510602986886%
Interest burden factor: 0.9331084360409873
Tax burden factor: 0.8282296790924775
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MGF (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.0332724568697953
ROE archetype: Standard Business
DuPont ROE decomposition for MGF (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.0300545792952902
ROE archetype: Standard Business
DuPont ROE decomposition for MGF (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.0230628996978168
ROE archetype: Standard Business
DuPont ROE decomposition for MGH.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.2354826730034993
ROE archetype: Standard Business
DuPont ROE decomposition for MGR.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.665157371617891
ROE archetype: Standard Business
DuPont ROE decomposition for MGRX (annual period ending 2022-12-31)
ROE: -325.4002247447193%
Net margin: -22352.10873699519%
Asset turnover: 0.008909713770835265
Equity multiplier (leverage): 1.6339380812012443
EBIT margin: -22279.695715404407%
ROE archetype: Low Return
DuPont ROE decomposition for MGRX (annual period ending 2023-12-31)
ROE: -1326.6882394958466%
Net margin: -1259.3992013594113%
Asset turnover: 0.712234187568157
Equity multiplier (leverage): 1.4790492978029701
EBIT margin: -1260.2841038806932%
ROE archetype: Low Return
DuPont ROE decomposition for MGRX (annual period ending 2024-12-31)
ROE: -118.29160473761809%
Net margin: -1413.6266730316154%
Asset turnover: 0.0750090248618502
Equity multiplier (leverage): 1.1155927233260339
EBIT margin: -1411.5777116386007%
ROE archetype: Low Return
DuPont ROE decomposition for MGRX (annual period ending 2025-12-31)
ROE: -141.66179288790067%
Net margin: -4526.763899030966%
Asset turnover: 0.028990450248003154
Equity multiplier (leverage): 1.0794683910298954
EBIT margin: -4200.461820837198%
ROE archetype: Low Return
DuPont ROE decomposition for MGX (annual period ending 2022-12-31)
Net margin: -253.44767441860463%
Asset turnover: 0.04149717963936056
EBIT margin: -259.5348837209302%
ROE archetype: Standard Business
DuPont ROE decomposition for MGX (annual period ending 2023-12-31)
Net margin: -152.50469210832068%
Asset turnover: 0.11485792888231913
EBIT margin: -175.37760300294934%
ROE archetype: Standard Business
DuPont ROE decomposition for MGX (annual period ending 2024-12-31)
ROE: -157.25927492873188%
Net margin: -149.26474806386844%
Asset turnover: 0.1517026112459224
Equity multiplier (leverage): 6.94489941877449
EBIT margin: -169.99904388564872%
ROE archetype: Low Return
DuPont ROE decomposition for MGX (annual period ending 2025-12-31)
ROE: -44.66505529249999%
Net margin: -348.5442284807616%
Asset turnover: 0.09239475024830401
Equity multiplier (leverage): 1.3869560023687708
EBIT margin: -380.8528361761206%
ROE archetype: Low Return
DuPont ROE decomposition for MGY (annual period ending 2022-12-31)
ROE: 60.35251302874225%
Net margin: 61.980132110312645%
Asset turnover: 0.658673279988805
Equity multiplier (leverage): 1.4783348494504338
EBIT margin: 63.36916115911957%
Interest burden factor: 0.9842622272966867
Tax burden factor: 0.9937192907094136
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MGY (annual period ending 2023-12-31)
ROE: 24.43396223811084%
Net margin: 36.07266302031249%
Asset turnover: 0.4605084708548884
Equity multiplier (leverage): 1.4708828027808976
EBIT margin: 44.84347327867877%
Interest burden factor: 0.9992584784268111
Tax burden factor: 0.8050097124107877
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MGY (annual period ending 2024-12-31)
ROE: 20.640551647612956%
Net margin: 30.194864904710588%
Asset turnover: 0.4718931205757308
Equity multiplier (leverage): 1.4485869328627525
EBIT margin: 38.908233691976356%
Interest burden factor: 0.9631924966991414
Tax burden factor: 0.8057095000841541
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MGY (annual period ending 2025-12-31)
ROE: 17.006382706764832%
Net margin: 25.710278272204413%
Asset turnover: 0.45837237267351594
Equity multiplier (leverage): 1.4430678036222875
EBIT margin: 33.478116698237976%
Interest burden factor: 0.9504304603341219
Tax burden factor: 0.808026142099753
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MHD (quarterly period ending 2025-01-31)
Equity multiplier (leverage): 1.5940754617544717
ROE archetype: Standard Business
DuPont ROE decomposition for MHD (quarterly period ending 2026-01-31)
Equity multiplier (leverage): 1.6610969504801827
ROE archetype: Standard Business
DuPont ROE decomposition for MIAX (annual period ending 2022-12-31)
Net margin: 7.2128875236709495%
Asset turnover: 1.0563244913440115
EBIT margin: 0.9715271850902159%
Interest burden factor: 6.463622291021672
Tax burden factor: 1.1486249151798187
ROE archetype: Standard Business
DuPont ROE decomposition for MIAX (annual period ending 2023-12-31)
ROE: -25.526351161455086%
Net margin: -2.006710809821644%
Asset turnover: 1.4113282393900284
Equity multiplier (leverage): 9.013135867639331
EBIT margin: -0.013736699176854718%
ROE archetype: Low Return
DuPont ROE decomposition for MIAX (annual period ending 2024-12-31)
ROE: 38.43559817688437%
Net margin: 8.957592152074605%
Asset turnover: 1.34641398198045
Equity multiplier (leverage): 3.186865588504285
EBIT margin: -0.24779136756275041%
Tax burden factor: 0.9718502869215176
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MIAX (annual period ending 2025-12-31)
ROE: -11.21689782594419%
Net margin: -5.133816152068108%
Asset turnover: 1.2216986793105116
Equity multiplier (leverage): 1.7884151801088228
EBIT margin: 6.954833062453403%
Interest burden factor: -0.7228810254139919
ROE archetype: Low Return
DuPont ROE decomposition for MIDWESTLTD.NS (quarterly period ending 2024-12-31)
Net margin: 12.385050846589307%
EBIT margin: 14.541868388022234%
Interest burden factor: 1.1793200634137748
Tax burden factor: 0.7221807318894697
ROE archetype: Standard Business
DuPont ROE decomposition for MIDWESTLTD.NS (quarterly period ending 2025-03-31)
ROE: 7.662847366074113%
Net margin: 21.05254011972926%
Asset turnover: 0.21742325493529802
Equity multiplier (leverage): 1.6740933773137974
EBIT margin: 29.03999374418948%
Interest burden factor: 0.9828261975286479
Tax burden factor: 0.7376175834880819
ROE archetype: Standard Business
DuPont ROE decomposition for MIDWESTLTD.NS (quarterly period ending 2025-12-31)
Net margin: 14.208774067377014%
EBIT margin: 17.01110533381966%
Interest burden factor: 1.0264142335766422
Tax burden factor: 0.8137695008667052
ROE archetype: Standard Business
DuPont ROE decomposition for MIDWESTLTD.NS (quarterly period ending 2026-03-31)
ROE: 3.783567240764379%
Net margin: 17.155765621741853%
Asset turnover: 0.15789392817529185
Equity multiplier (leverage): 1.396773293572647
EBIT margin: 23.13848149950187%
Interest burden factor: 1.0158409100012016
Tax burden factor: 0.7298767865943815
ROE archetype: Low Return
DuPont ROE decomposition for MIND.L (annual period ending 2022-03-31)
ROE: 8.162641394069093%
Net margin: 3.2916906386126406%
Asset turnover: 1.405046480743692
Equity multiplier (leverage): 1.7649036991745644
EBIT margin: -0.7171036409961371%
ROE archetype: Standard Business
DuPont ROE decomposition for MIND.L (annual period ending 2023-03-31)
ROE: 13.422915720144305%
Net margin: 5.3352965770482275%
Asset turnover: 1.480126897272473
Equity multiplier (leverage): 1.6997668170070137
EBIT margin: 5.6043336787188025%
Interest burden factor: 0.9614012325656828
Tax burden factor: 0.9902159244264508
ROE archetype: Standard Business
DuPont ROE decomposition for MIND.L (annual period ending 2024-03-31)
ROE: -63.88229631419038%
Net margin: -24.241884490359354%
Asset turnover: 1.5258148857411036
Equity multiplier (leverage): 1.7270793592270914
EBIT margin: -26.748897893752506%
ROE archetype: Low Return
DuPont ROE decomposition for MIND.L (annual period ending 2025-03-31)
ROE: -108.5618633686295%
Net margin: -21.211728746826918%
Asset turnover: 2.2561159913450335
Equity multiplier (leverage): 2.2685053112047124
EBIT margin: -15.66595865927576%
ROE archetype: Low Return
DuPont ROE decomposition for MIND.L (annual period ending 2026-03-31)
ROE: -554.6342397548835%
Net margin: -17.610862149688984%
Asset turnover: 2.917007730066557
Equity multiplier (leverage): 10.796636483011442
EBIT margin: -16.758076382850646%
ROE archetype: Low Return
DuPont ROE decomposition for MINE.V (quarterly period ending 2024-12-31)
ROE: -5.299490908625773%
Asset turnover: 0
Equity multiplier (leverage): 1.0923551551897261
ROE archetype: Low Return
DuPont ROE decomposition for MINE.V (quarterly period ending 2025-03-31)
ROE: -5.041247721658327%
Asset turnover: 0
Equity multiplier (leverage): 1.1094754134866407
ROE archetype: Low Return
DuPont ROE decomposition for MINE.V (quarterly period ending 2025-06-30)
ROE: -5.345582516722405%
Asset turnover: 0
Equity multiplier (leverage): 1.1361464302092512
ROE archetype: Low Return
DuPont ROE decomposition for MINE.V (quarterly period ending 2025-09-30)
ROE: 2.1147343783601804%
Asset turnover: 0
Equity multiplier (leverage): 1.677832472335743
Tax burden factor: 1
ROE archetype: Low Return